Form 4 · EMR
Emerson Exec VP Michael J. Baughman reports 2,003 shares withheld for taxes
Part of a grouped insider digest: see all related filings with totals →
Michael J. Baughman, Emerson's Exec VP, CFO & CAO, filed a Form 4 on Nov 10, 2026 at 4:14 PM ET reporting transactions on Nov 6, 2026.
The filing reports 2,003 shares withheld to pay the exercise price or tax (code F).
After these transactions, the filing lists 145,469 shares held directly.
Effect on holdings
Taken together, the rows reported here lowered Michael J. Baughman's directly held shares by 1.4%, from 147,472 to 145,469.
Reporting person
- Michael J. Baughman, Exec VP, CFO & CAO (as filed: Baughman Michael J)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-06 | F | Common Stock | 2,003 | $163.06 | Disposed | 145,469 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 10, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Emerson company file → · More Emerson filings
Disclosures
- Editor holdings in EMR
- The editor holds no position in Emerson (EMR). As of Nov 11, 2026.
- Last updated
- Nov 10, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold EMR.